抗结核药物向物MmpL3的晶体结构
Bing Zhang1, Jun Li2, Xiaolin Yang1
1Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China; CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, 200031, China; University of Chinese Academy of Sciences, Beijing, 100101, China.
新的研究揭示了Mycobacterium结核病膜蛋白Large 3 (MmpL3) 的晶体结构及其与结核病药物候选物的复合物. 这种结构洞察对于开发针对MmpL3的新型结核病治疗至关重要.
科学领域:
- 结构生物学
- 药物发现
- 菌研究
背景情况:
- 结核病 (TB) 仍然是一个重大的全球健康威胁,需要新的治疗策略.
- 大型菌膜蛋白 (MmpLs),特别是MmpL3,对于菌膜的生存至关重要,并且正在成为关键的药物标.
- MmpL3在运输必需分子和挤出药物中的作用使其成为新的抗结核药物的有希望的目标.
研究的目的:
- 阐明MmpL3功能的结构基础及其与潜在的结核病药物候选物的相互作用.
- 提供高分辨率的结构数据,以指导MmpL3抑制剂的合理设计.
- 推进针对MmpL3的新药的开发,以消除结核病.
主要方法:
- 使用X射线结晶学来确定MmpL3的结构.
- 进行了联合结晶,以获得MmpL3与结核病候选药物 (SQ109, AU1235, ICA38, rimonabant) 的复合结构.
- 结构分析侧重于跨膜领域和关键的质子转移促进残留物.
主要成果:
- 确定单独的MmpL3和与四种候选药物的结晶结构.
- MmpL3包括一个周等离子孔域和一个十二螺旋转膜域.
- 药物候选物与外膜区域结合,破坏参与质子转移的关键Asp-Tyr对.
结论:
- 确定结构为MmpL3的作用机制提供了前所未有的洞察力.
- 药物候选物对Asp-Tyr的破坏凸显了MmpL3的一个关键漏洞.
- 这些结构信息对于加速开发新型MmpL3抑制剂作为有效的结核治疗药物至关重要.
更多相关视频
09:55From Constructs to Crystals – Towards Structure Determination of β-barrel Outer Membrane Proteins
Published on: July 4, 2016
18:45Harvesting and Cryo-cooling Crystals of Membrane Proteins Grown in Lipidic Mesophases for Structure Determination by Macromolecular Crystallography
Published on: September 2, 2012
相关概念视频
Cellular Membranes and Drug Transport
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Ionic Crystal Structures
Most monatomic ions behave as charged spheres, and their attraction for ions of opposite charge is the same in every direction. Consequently, stable structures for ionic compounds result (1) when ions of one charge are surrounded by as many ions as possible of the opposite...
Drug Absorption Mechanism: Passive Membrane Transport
Membrane Transporters
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
